The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 7.24% this year. Over the last six months, there has been a stronger performance of -19.68%. The price of OGN fallen by 5.82% during the last 30 days period. For the last 5-days stocks have improved 7.24%.
Organon & Co experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $23.10 on 08/26/24, while the lowest price for the same period was registered at $13.87 on 12/23/24.
52-week price history of OGN Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Organon & Co’s current trading price is -30.74% away from its 52-week high, while its distance from the 52-week low is 15.36%. The stock’s price range during this time has been between $13.87 and $23.10. The trading volume for the Healthcare sector company’s shares reached about 3.89 million for the day, which was higher than the average daily volume of 3.28 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Organon & Co (OGN) has experienced a quarterly decline of -11.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.12B and boasts a workforce of 10000 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 17.64, with a change in price of -4.22. Similarly, Organon & Co recorded 2,764,445 in trading volume during the last 100 days, posting a change of -20.87%.
OGN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for OGN stands at 17.75. Similarly, the long-term debt-to-equity ratio is also 17.73.
OGN Stock Stochastic Average
Today, Organon & Co’s raw stochastic average for the past 50 days stands at 41.16%, indicating a decline from the raw stochastic average of the last 20 days, which was 98.27%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 85.96% and 77.24% respectively.
